Cibus, Inc. (NASDAQ:CBUS - Free Report) - HC Wainwright decreased their FY2030 earnings per share (EPS) estimates for shares of Cibus in a research report issued to clients and investors on Friday, November 13th. HC Wainwright analyst A. Dayal now anticipates that the company will earn $2.05 per share for the year, down from their prior forecast of $2.08. The consensus estimate for Cibus' current full-year earnings is ($1.13) per share.
A number of other research analysts also recently weighed in on CBUS. Wall Street Zen downgraded shares of Cibus from a "hold" rating to a "sell" rating in a research report on Saturday, October 17th. Weiss Ratings reiterated a "sell (e+)" rating on shares of Cibus in a research note on Friday, September 25th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $9.00.
Read Our Latest Report on Cibus
Cibus Price Performance
Shares of CBUS stock opened at $1.13 on Monday. The company's fifty day simple moving average is $1.43 and its 200-day simple moving average is $1.82. The firm has a market cap of $86.37 million, a PE ratio of -0.75 and a beta of 1.65. Cibus has a 12 month low of $1.02 and a 12 month high of $4.19.
Cibus (NASDAQ:CBUS - Get Free Report) last issued its quarterly earnings results on Thursday, November 12th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.09). Cibus had a negative return on equity of 526.66% and a negative net margin of 2,131.38%. The business had revenue of $0.80 million for the quarter, compared to the consensus estimate of $1.30 million.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the stock. Weiss Asset Management LP acquired a new position in shares of Cibus during the 1st quarter worth approximately $1,758,000. Renaissance Technologies LLC raised its stake in shares of Cibus by 42.5% during the 1st quarter. Renaissance Technologies LLC now owns 98,900 shares of the company's stock worth $196,000 after purchasing an additional 29,500 shares in the last quarter. Bank of America Corp DE raised its stake in shares of Cibus by 324.2% during the 1st quarter. Bank of America Corp DE now owns 74,358 shares of the company's stock worth $147,000 after purchasing an additional 56,830 shares in the last quarter. OMERS ADMINISTRATION Corp bought a new stake in shares of Cibus during the 1st quarter worth approximately $66,000. Finally, StoneX Group Inc. boosted its holdings in shares of Cibus by 115.9% in the 3rd quarter. StoneX Group Inc. now owns 30,605 shares of the company's stock valued at $50,000 after buying an additional 16,430 shares during the last quarter. 33.81% of the stock is owned by institutional investors and hedge funds.
About Cibus
(
Get Free Report)
Cibus is an agricultural technology company that develops plant traits using gene-editing technologies. Its proprietary Rapid Trait Development System (RTDS) is designed to make precise changes to a plant's own genes, with the goal of developing useful crop characteristics without adding foreign DNA. The company's research and development focuses on traits for crops including canola, rice and wheat, such as herbicide tolerance and resistance to crop diseases. Cibus aims to bring these traits to market through seed and technology licensing arrangements with partners in the agricultural industry.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cibus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cibus wasn't on the list.
While Cibus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.